Organism group |
Effect | |
mammalian | Effect on estrogen 20% reduction of [3H]17-beta-estradiol binding to ER |
Show study |
mammalian | Effect on androgen 30-40% inhibition of [3H]5-alpha-DHT binding to AR |
Show study |
mammalian | Effect on androgen 20-30% decrease in [3H]5-alpha-DHT binding to SHBG |
Show study |
mammalian | suspected no endocrine effect No inhibition of aromatase activity |
Show study |
mammalian | Effect on thyroid hormone F2 and F3 males: decreased serum T4 levels |
Show study |
mammalian | Effect on thyroid hormone F3 females: decreased serum T4 levels |
Show study |
mammalian | suspected no endocrine effect No effect on serum cortisol, testosterone and estradiol levels |
Show study |
mammalian | Effect on thyroid hormone Decreased serum T4 levels |
Show study |
mammalian | suspected endocrine effect Increased severity of oviductal intraepithelial cysts |
Show study |
mammalian | Effect on thyroid hormone Decreased serum T4 levels |
Show study |
mammalian | suspected endocrine effect Increased thyroid follicle size |
Show study |
mammalian | suspected no endocrine effect No induction of cell proliferation |
Show study |
yeast | Effect on progestogen Inhibition of hPR activity |
Show study |
yeast | Effect on progestogen Reduction of R5020 binding to hPR |
Show study |
yeast | suspected no endocrine effect Cytotoxic |
Show study |